This HTML5 document contains 49 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n11http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F61989592%3A15110%2F10%3A10221957%21RIV11-MSM-15110___/
dctermshttp://purl.org/dc/terms/
n7http://localhost/temp/predkladatel/
n16http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n5http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n8http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n17http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n15http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n14http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n9http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F61989592%3A15110%2F10%3A10221957%21RIV11-MSM-15110___
rdf:type
n5:Vysledek skos:Concept
dcterms:description
The Lapatinib Expanded Access Program (LEAP) was designed to provide access to lapatinib plus capecitabine for HER2-positive metastatic breast cancer patients who previously received an anthracycline, a taxane, and a trastuzumab and had no other treatment options. The Lapatinib Expanded Access Program (LEAP) was designed to provide access to lapatinib plus capecitabine for HER2-positive metastatic breast cancer patients who previously received an anthracycline, a taxane, and a trastuzumab and had no other treatment options.
dcterms:title
An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer
skos:prefLabel
An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer
skos:notation
RIV/61989592:15110/10:10221957!RIV11-MSM-15110___
n3:aktivita
n17:S
n3:aktivity
S
n3:cisloPeriodika
3
n3:dodaniDat
n9:2011
n3:domaciTvurceVysledku
n16:6299679
n3:druhVysledku
n15:J
n3:duvernostUdaju
n8:S
n3:entitaPredkladatele
n11:predkladatel
n3:idSjednocenehoVysledku
246262
n3:idVysledku
RIV/61989592:15110/10:10221957
n3:jazykVysledku
n12:eng
n3:klicovaSlova
cancer; breast; metastatic; advanced; locally; HER2-overexpressing; patients; capecitabine; lapatinib; study; expanded; open-label
n3:klicoveSlovo
n6:breast n6:cancer n6:advanced n6:metastatic n6:study n6:HER2-overexpressing n6:locally n6:lapatinib n6:patients n6:expanded n6:capecitabine n6:open-label
n3:kodStatuVydavatele
GB - Spojené království Velké Británie a Severního Irska
n3:kontrolniKodProRIV
[C5B41FFAF6A9]
n3:nazevZdroje
anals oncology
n3:obor
n14:FD
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
18
n3:rokUplatneniVysledku
n9:2010
n3:svazekPeriodika
21
n3:tvurceVysledku
Capri, G. Chen, Cs Chang, J. Conte, P. Cwiertka, Karel
s:issn
0923-7534
s:numberOfPages
7
n7:organizacniJednotka
15110